FDA Import Refusal SCS-4770533-3/31/1A — Ajanta Pharma Limited
The FDA refused shipment SCS-4770533-3/31/1A from Ajanta Pharma Limited (India) on December 19, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 19, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75